TY  - JOUR 
AU  - Souto Vilas, Alejandro
AU  - Maneiro Fernández, José Ramón
AU  - Salgado Pérez, Eva
AU  - Carmona Ortells, Loreto
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2014
SN  - 1462-0324
UR  - http://hdl.handle.net/20.500.11940/6632
AB  - OBJECTIVE: The aim of this study was to assess the risk of active tuberculosis (TB) in patients with immune-mediated inflammatory diseases treated with biologics and tofacitinib in randomized controlled trials (RCTs) and long-term extension (LTE)...
LA  - eng
KW  - Biological Products
KW  - Humans
KW  - Incidence
KW  - Latent Tuberculosis
KW  - Piperidines
KW  - Pyrimidines
KW  - Pyrroles
TI  - Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies
DO  - 10.1093/rheumatology/keu172
T2  - RHEUMATOLOGY
M2  - 1872
VL  - 53
ER  -